COVID hasn't disappeared, but it has changed. For most people it's now a manageable respiratory illness rather than an emergency — while still carrying real risk for some. Here's a plain-English guide to boosters, testing, treatment, and long COVID as things actually stand in 2026.
If it feels like nobody quite agrees on how seriously to take COVID anymore, that's fair — the honest answer sits between the two loud extremes. COVID is no longer a public-health emergency, but it isn't gone either. It has settled into the same category as flu and other respiratory viruses: something we live alongside, most of us handle at home, and a smaller group of people still need to take seriously. The goal in 2026 isn't fear or dismissal. It's knowing which one you are.
SARS-CoV-2 is now endemic — it circulates year-round with roughly seasonal surges, typically a winter wave and often a second bump in late summer. The virus keeps evolving; the Omicron family and its descendants have continued to spin off new variants that spread easily but, for most people, cause milder illness than the strains of 2020 and 2021.
The reason most cases are milder now isn't luck — it's immunity. Between vaccination and prior infection, nearly everyone has some background protection, and that layered immunity is what turned a novel, lethal virus into, for most, a few unpleasant days of cough, sore throat, congestion, and fatigue. What hasn't changed is that COVID is not uniformly mild — for older adults and people with certain conditions, it can still cause pneumonia, hospitalization, and death. Both things are true at once.
The vaccine strategy has matured into something that looks a lot like the flu shot model: the formula is updated periodically to track the variants actually circulating, and an updated dose is offered ahead of the respiratory season. The older primary-series-plus-boosters language has largely given way to a simpler idea — stay reasonably current, especially if you're in a higher-risk group.
Vaccination today is less about preventing every infection — it doesn't — and more about blunting severity. It meaningfully lowers the odds of severe disease, hospitalization, and death, and that benefit is largest exactly where the risk is largest.
For a healthy younger adult with no risk factors, it's more of a judgment call. For everyone on the list above, the reasoning is straightforward: these are the people COVID is most likely to send to the hospital, and the vaccine is the cheapest, safest way to lower that chance.
The conversation I have most often now isn't "should you get a COVID shot" in the abstract — it's timing. I tell my higher-risk patients to line the updated COVID dose up with their flu shot in the fall, get both in one visit, and be done for the season. And the patients who benefit most are frequently the ones most tempted to skip it because they "feel fine." Feeling fine is exactly the point — the shot is there to keep an infection from taking that away.
Home rapid antigen tests are the workhorse now, and they're genuinely useful when you understand their quirks. A positive result is reliable — if the line shows up, you have COVID. A negative result is trickier, because antigen tests need a fair amount of virus to turn positive, and early in an illness there may not be enough yet.
That's why timing and repeat testing matter. If you have symptoms but test negative, don't take that first result as the final word — wait 48 hours and test again, since testing right at the first tickle in your throat is often too early. If you were exposed but feel well, waiting a few days before testing gives a more meaningful result.
A PCR test or a visit to the office makes sense when the answer really matters — you're higher-risk and want to start treatment quickly, or you're sick enough to wonder whether it's COVID versus flu (which changes which antiviral you'd use). For most healthy people with mild symptoms, a home test and some common sense are enough.
For the majority of healthy patients, COVID treatment is the same supportive care we'd use for any viral illness: rest, fluids, acetaminophen or ibuprofen for fever and aches, and time. Most people turn the corner within about a week.
The antiviral that changed outpatient care is nirmatrelvir-ritonavir (Paxlovid), a short oral course that reduces the risk of severe disease and hospitalization. The key word is risk — the benefit is concentrated in people who have something to prevent. It's most valuable for those at higher risk of severe illness: older adults, the immunocompromised, and people with significant chronic conditions.
Two details decide whether Paxlovid helps. First, timing — it works best when started early, within about five days of symptoms starting, so a higher-risk patient shouldn't wait to see how things go. Second, drug interactions — the ritonavir component interacts with a long list of common medications (certain cholesterol drugs, blood thinners, and others), which is exactly why this is a prescription and a quick conversation rather than something to guess at. Often we can pause or adjust a medication for the five-day course.
Some patients finish the course, test negative, feel better — and then a few days later symptoms and a positive test come back. This is rebound, and understanding it keeps it from alarming you. The rebound is almost always mild, it resolves on its own, and it does not mean the medication failed or that you need another course. It does mean you're contagious again, so it's a moment to go back to precautions for a few days. Rebound can also happen without any treatment at all — it's partly just how some people's immune response to this virus behaves.
If you're in one of these groups, it's worth being more proactive — staying current on the updated vaccine, testing sooner when symptoms start, and having a plan to reach a doctor quickly so antivirals can begin in that early window:
For everyone in these groups, the strategy isn't to live in fear of the virus — it's to have the plan ready so that if COVID does show up, treatment starts in the window where it does the most good.
Long COVID is real. A meaningful minority of people have symptoms that persist for weeks or months after the acute infection clears, and dismissing it does patients a disservice. The most common features are persistent fatigue, "brain fog" (trouble with memory and concentration), shortness of breath, and post-exertional malaise — a pattern where physical or mental effort is followed a day or two later by a crash. Others describe lingering loss of smell or taste, palpitations, or sleep disruption.
Here's the honest part: there is no single test that diagnoses it and no single pill that cures it. What genuinely helps is careful evaluation — ruling out other treatable causes of the same symptoms (thyroid problems, anemia, heart or lung disease, depression) rather than assuming everything is long COVID — followed by targeted support. Managing specific symptoms, careful and gradual return to activity (pushing too hard too fast tends to backfire with post-exertional malaise), and treating sleep and mood all move people forward. Most patients improve over time, and having a physician who takes the symptoms seriously makes a real difference. Staying current on vaccination also appears to lower the odds of developing long COVID in the first place.
The patients I see with long COVID are usually more frustrated by not being believed than by any single symptom. So the first thing I do is take the whole picture seriously and rule out the things that mimic it — a low thyroid or quiet anemia can look a lot like "long COVID fatigue," and those are fixable. From there it's unglamorous but effective work: pacing activity so we don't trigger a crash, protecting sleep, and treating each symptom on its own terms. There's no magic fix, but people do get better, and steady, honest follow-up is most of the medicine.
The everyday habits that reduce spread are simple:
The right amount of caution scales with your risk and the situation — more around vulnerable people or during a surge, less when you're healthy and life is quiet.
Dr. Sharma treats COVID the way it deserves to be treated now — practically and individually. That means an honest read on your personal risk, vaccination timed sensibly rather than reflexively, prompt antiviral treatment for those who benefit, and a thorough, respectful evaluation for anyone struggling with long COVID rather than being told it is nothing. Care is available in person at our San Jose and Campbell offices or by telemedicine anywhere in California — often the fastest way to start antivirals inside that narrow early window.
Guidance shifts as the virus and the evidence evolve, and care is individual. Trouble breathing, chest pain, or new confusion are emergencies — call 911.
Whether you need same-day testing and treatment or an updated booster before the season, Dr. Sharma can help — in person or by video, and fast enough to start antivirals when they matter.